MedTrace Logo

Interstitial Lung Diseases in the Veterans Administration

NCT02479126 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2022-07-26

No results posted yet for this study

Summary

The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.

Conditions

Sponsors & Collaborators

  • Durham VA Medical Center

    collaborator FED

  • Boehringer Ingelheim

    collaborator INDUSTRY

  • Robert Tighe

    lead FED

Principal Investigators

  • Robert M Tighe, MD · Duke University Department of Medicine and Durham VA Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2022-11-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02479126 on ClinicalTrials.gov